Patent · US4127675A · A · US
4-(Alkylamino-2-hydroxypropoxy)-indenes and method of use
- (11) Publication number
- US4127675A
- (21) Application number
- 05/734,514
- (22) Filing date
- 1976-10-21
- (30) Priority date
- 1968-11-12
- (43) Publication date
- 1978-11-28
- (45) Date of grant
- 1978-11-28
- (51) IPC
- A61K 31/135; F16B 2/06
- (52) CPC
- (73) Assignee
- Yamanouchi Pharmaceutical Co Ltd
- (72) Inventors
- Masuo Murakami; Kiyoshi Murase; Kunihiro Niigata; Shiro Tachikawa; Toichi Takenaka
- (54) Title
- 4-(Alkylamino-2-hydroxypropoxy)-indenes and method of use
- (57) Abstract
Novel indene derivatives represented by the general formula wherein R represents lower alkyl, phenylloweralkyl or lower cycloalkyl, and acid addition salts thereof useful as beta -receptor antagonists.
- Full text
- View on Google Patents
Claims (7)
- A method of establishing an adrenergic β-receptor blockade which comprises administering to a patient in which such blockade is desired a pharmaceutically effective amount of a compound selected from the group consisting of 4-(3-isopropylamino-2-hydroxypropoxy)indene, 4-(3-tert-butylamino-2-hydroxypropoxy)indene and a non-toxic acid addition salt thereof.
- A method according to claim 1, wherein the compound is 4-(3-isopropylamino-2-hydroxypropoxy)indene.
- A method according to claim 1, wherein the compound is 4-(3-tert-butylamino-2-hydroxypropoxy)indene.
- A compound selected from the group consisting of 4-(3-tert-butylamino-2-hydroxypropoxy)indene and a non-toxic acid addition salt thereof.
- A pharmaceutical composition which comprises, as active ingredient, a compound selected from the group consisting of 4-(3-isopropylamino-2-hydroxypropoxy)indene, 4-(3-tert-butylamino-2-hydroxypropoxy)indene and a non-toxic acid addition salt thereof, and a pharmaceutically acceptable carrier therefor.
- A composition as claimed in claim 5, wherein the active ingredient is 4-(3-isopropylamino-2-hydroxypropoxy)indene.
- A composition as claimed in claim 5, wherein the active ingredient is 4-(3-tert-butylamino-2-hydroxypropoxy)indene.
Description
This application is a divisional of Ser. No. 568,097, filed Apr. 14, 1975, now U.S. Pat. No. 4,045,482 which is a continuation of Ser. No. 141,936, filed May 10, 1971, now abandoned, which is a continuation-in-part of Ser. No. 876,070, filed Nov. 12, 1969, now abandoned.
This invention relates to novel indene derivatives having valuable therapeutic properties, non-toxic salts thereof, and to processes for their production.
The therapeutically active compounds of this invention are represented by the general formula ##STR2## wherein R represents a lower alkyl, phenylloweralkyl or lower cycloalkyl group.
The term "lower alkyl" as used herein means both straight and branched chain aliphatic hydrocarbon groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl, amyl, hexyl, etc. The term "phenylloweralkyl", which may contain more than one phenyl group, is represented by groups such as benzyl, diphenylmethyl, β-phenylisopropyl, etc. The term "lower cycloalkyl" is represented by groups such as cyclopentyl and cyclohexyl, etc.
The compounds I of the present invention can be prepared by reacting a compound of the general formula ##STR3## wherein A represents a hydrogen atom or a 2,3-epoxypropyl group with an amine of the general formula
wherein R is defined as above and B represents a 3-halogeno-2-hydroxypropyl group when A is a hydrogen atom; and when A is a 2,3-epoxypropyl group, B is a hydrogen atom.
Citations (3)
- US3051709A
- US3234211A
- US3415873A
Record as JSON
{
"publication_number": "US4127675A",
"country": "US",
"kind": "A",
"title": "4-(Alkylamino-2-hydroxypropoxy)-indenes and method of use",
"abstract": "Novel indene derivatives represented by the general formula wherein R represents lower alkyl, phenylloweralkyl or lower cycloalkyl, and acid addition salts thereof useful as beta -receptor antagonists.",
"claims": [
"1. A method of establishing an adrenergic β-receptor blockade which comprises administering to a patient in which such blockade is desired a pharmaceutically effective amount of a compound selected from the group consisting of 4-(3-isopropylamino-2-hydroxypropoxy)indene, 4-(3-tert-butylamino-2-hydroxypropoxy)indene and a non-toxic acid addition salt thereof.",
"2. A method according to claim 1, wherein the compound is 4-(3-isopropylamino-2-hydroxypropoxy)indene.",
"3. A method according to claim 1, wherein the compound is 4-(3-tert-butylamino-2-hydroxypropoxy)indene.",
"4. A compound selected from the group consisting of 4-(3-tert-butylamino-2-hydroxypropoxy)indene and a non-toxic acid addition salt thereof.",
"5. A pharmaceutical composition which comprises, as active ingredient, a compound selected from the group consisting of 4-(3-isopropylamino-2-hydroxypropoxy)indene, 4-(3-tert-butylamino-2-hydroxypropoxy)indene and a non-toxic acid addition salt thereof, and a pharmaceutically acceptable carrier therefor.",
"6. A composition as claimed in claim 5, wherein the active ingredient is 4-(3-isopropylamino-2-hydroxypropoxy)indene.",
"7. A composition as claimed in claim 5, wherein the active ingredient is 4-(3-tert-butylamino-2-hydroxypropoxy)indene."
],
"description_excerpt": "This application is a divisional of Ser. No. 568,097, filed Apr. 14, 1975, now U.S. Pat. No. 4,045,482 which is a continuation of Ser. No. 141,936, filed May 10, 1971, now abandoned, which is a continuation-in-part of Ser. No. 876,070, filed Nov. 12, 1969, now abandoned.\n\nThis invention relates to novel indene derivatives having valuable therapeutic properties, non-toxic salts thereof, and to processes for their production.\n\nThe therapeutically active compounds of this invention are represented by the general formula ##STR2## wherein R represents a lower alkyl, phenylloweralkyl or lower cycloalkyl group.\n\nThe term \"lower alkyl\" as used herein means both straight and branched chain aliphatic hydrocarbon groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl, amyl, hexyl, etc. The term \"phenylloweralkyl\", which may contain more than one phenyl group, is represented by groups such as benzyl, diphenylmethyl, β-phenylisopropyl, etc. The term \"lower cycloalkyl\" is represented by groups such as cyclopentyl and cyclohexyl, etc.\n\nThe compounds I of the present invention can be prepared by reacting a compound of the general formula ##STR3## wherein A represents a hydrogen atom or a 2,3-epoxypropyl group with an amine of the general formula\n\nwherein R is defined as above and B represents a 3-halogeno-2-hydroxypropyl group when A is a hydrogen atom; and when A is a 2,3-epoxypropyl group, B is a hydrogen atom.",
"cpc": [
"A61K 31/135",
"F16B 2/06"
],
"ipc": [
"A61K 31/135",
"F16B 2/06"
],
"assignees": [
"Yamanouchi Pharmaceutical Co Ltd"
],
"inventors": [
"Masuo Murakami",
"Kiyoshi Murase",
"Kunihiro Niigata",
"Shiro Tachikawa",
"Toichi Takenaka"
],
"filing_date": "1976-10-21",
"publication_date": "1978-11-28",
"grant_date": "1978-11-28",
"priority_date": "1968-11-12",
"application_number": "US-73451476-A",
"family_id": "27300987",
"cited_by_count": 5,
"citations": [
"US3051709A",
"US3234211A",
"US3415873A"
]
}
Record 7,727 of 8,000 in Patents full text (MLC-0201). Request the full dataset.